ArticleAMB Express2025
Exploring putative links between gut microbiota and allergic rhinitis: insights from Mendelian randomization and multi-transcriptome integration.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of EGR2 and TGFB1 as Potential Immunoregulatory Biomarkers for Allergic Rhinitis: An Exploratory Bioinformatics and Pilot Validation Study.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Allergic rhinitis (AR) is a common immune-related disorder recently associated with gut microbiota (GM), though the underlying mechanisms remain unclear. This study employed Mendelian randomization (MR) to investigate causal relationships between GM and AR, combined with transcriptomic analyses, including both bulk and single-cell RNA sequencing (scRNA-seq), to explore molecular mechanisms at tissue and cellular resolutions. Data for AR and GM were sourced from public databases. MR identified causal microbial taxa, whose associated SNPs were mapped to genes. These were intersected with differentially expressed genes (DEGs) from transcriptomic data to identify candidate genes. Key genes were validated through expression analysis, immune infiltration, functional enrichment, regulatory network prediction, drug screening, and molecular docking. Single-cell RNA sequencing was used to identify key cell types and pseudotime trajectories. MR analysis identified 29 GM taxa causally linked to AR. For instance, family.Porphyromonadaceae.id.943 was protective, while genus.unknowngenus.id.1000006162 was a risk factor. SNP-based gene mapping yielded 246 genes, which overlapped with 1329 DEGs to identify INPP5D and KIF16B as key genes. These were enriched in pathways such as ribosome, peroxisome, and systemic lupus erythematosus. Immune infiltration revealed altered abundances of natural killer T cells and activated CD4 + T cells. Single-cell analysis highlighted Th1 cells as central to AR pathogenesis, with stable expression of INPP5D and KIF16B during Th1 differentiation. This study establishes a causal link between GM and AR and identifies INPP5D and KIF16B as potential key genes, with Th1 cells as a critical immune subset, providing new insights into AR's molecular mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.